BiotechTube
Home/Brain Trust Bio/Ali Almuzaini
AA

Ali Almuzaini

Business Development & Strategy

Brain Trust Bio

Therapeutic Areas

Amyotrophic Lateral SclerosisCentral Nervous System Diseases

Brain Trust Bio Pipeline

DrugIndicationPhase
ITRil (Intrathecal Riluzole)Amyotrophic Lateral Sclerosis (ALS)Phase 1

Leadership Team at Brain Trust Bio

CB
Chen Benkler, PhD
Co-Founder, CEO
NM
Nicholas M. Boulis, MD
Co-Founder, President
DR
Daniel R. Deaver, PhD
Pharmacology & Toxicology
LS
Lynn Scott, JD
Legal Counsel
RB
Robert Bowser, PhD
Chairman, Scientific Advisory Board
View full Brain Trust Bio profile